Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma

Fig. 5

Vγ9Vδ2 T cells and Car-B7H3-γδT cells infiltrated into tumor xenografts in mice Tumor-bearing mice received an intracranial injection of 5 × 106 Vγ9Vδ2 T cells A or Car-B7H3-γδT cells B, followed by multiplex immunofluorescence staining to detect human TCRδ2, B7H3, and Granzyme B expression in tumor xenografts on day 1, day 7, and day 14 after injection. C The percentage of activated Vγ9Vδ2T (TCRδ2+ and Granzyme B+) cells and Car-B7H3-γδT (B7H3+ and Granzyme B+) cells (number /mm2) in total Vγ9Vδ2 T cells at different time points was analyzed. Data are expressed as the mean ± SD

Back to article page